Texas A&M biologists zero in on 2-protein 2-step trigger for fibrotic disease
9/09/2015
Scientists at Texas A&M University have made additional progress in understanding the process behind scar-tissue formation and wound healing -- specifically, a breakthrough in fibroblast-to-fibrocyte...
Advanced treatment and prognosis data available for lung cancer TNM classification
9/09/2015
The publication of the Eighth Edition of the Tumor, Node and Metastasis (TNM) Classification of Lung Cancer will provide physicians around the world access to new data to more precisely stage and...
Study defines criteria for MET-driven lung cancer suitable for crizotinib treatment
9/09/2015
Many cancers include increased copies of the gene MET. But in which cases is MET driving the cancer and in which do these increased copies happen to "ride along" with other molecular abnormalities...
Personalized medicine's success needs accurate classification of tumors
9/09/2015
If cancer patients are to receive optimal treatment, clinicians must have an accurate histologic classification of the tumor and know its genetic characteristics, said William D. Travis, M.D.
Drugs behave as predicted in computer model of key protein, enabling cancer drug discovery
9/09/2015
New model allows pharmacological researchers to dock nearly any drug and see how it behaves in P-glycoprotein, a protein in the cell associated with failure of chemotherapyDrugs important in the...
Researchers identify mechanism that impairs blood flow with aging
9/09/2015
With the world's elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No.
Experts examine ways to address anemia and blood loss in surgery patients
9/09/2015
Anemia is common, and in surgical patients can increase various risks associated with operations.
Researchers develop a method for controlling gene activation
9/08/2015
The researchers at the University of Helsinki, Finland, have developed a new method which enables the activation of genes in a cell without changing the genome.
Rutgers Cancer Institute of New Jersey is one of a few East Coast sites to offer a clinical trial investigating an experimental drug known as REGN1979 in the treatment of non-Hodgkin's lymphoma (NHL)...
New risk score for colorectal cancer could guide screening test selection
9/08/2015
Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo...